Cognitive Testing Online in Parkinson's Disease

McGill University

Status: Enrolling

Conditions: Parkinson Disease

Treatments: Other: Neurocognitive testing

Study type: Observational

Funder types: Other

Identifiers

NCT05025254

2020-6045

Details and patient eligibility

About

This is a feasibility and pilot study. Though large-scale online neurocognitive testing is increasingly being done in psychiatry, there are no such efforts in Parkinson's research. Thus a large part of this pilot study will be to demonstrate feasibility and reliability, and use this experience to develop a feasible protocol for ongoing research. The specific short-term objectives are:

1. To establish the feasibility of performing large-scale deep cognitive phenotyping using online cognitive testing.
2. To demonstrate that online neurocognitive testing is valid and reliable in a smaller sample of locally recruited participants tested both in-lab and online.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 45 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• diagnosis of Parkinson's disease by neurologist or healthy individual with no diagnosis of any neurological illness

Exclusion criteria

• Psychotic spectrum disorders, active uncontrolled depression, advanced dementia (i.e. needing assistance with daily activities such as dressing or bathing), major stroke, major head injury, epilepsy requiring anti-seizure medications

Trial design

1,000 participants in 2 patient groups

PD patients

Description:

This is an observational study. The PD patient group will consist of participants who self-report that they have a diagnosis of Parkinson's disease

Treatment:

Other: Neurocognitive testing

Healthy controls

Description:

This is an observational study. The healthy control group will consist of participants who self-report that they do not have a diagnosis of Parkinson's disease

Treatment:

Other: Neurocognitive testing